Glax­o­SmithK­line R&D re­or­ga­ni­za­tion trig­gers lay­offs at Steve­nage -- and Up­per Prov­i­dence

GSK’s new R&D chief Hal Bar­ron has made no se­cret of the fact that he has a keen in­ter­est in re­fo­cus­ing the R&D group …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.